Ameritas Investment Partners
GALT icon

Ameritas Investment Partners’s Galectin Therapeutics GALT Stock Holding History

Ameritas Investment Partners’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Buy
+4,349
New +$11.3K ﹤0.01% 2752
2025
Q2 		– Sell
-1,995
Closed -$2.43K – 3249
2025
Q1 		$2.43K Hold
1,995
– – ﹤0.01% 3064
2024
Q4 		$2.57K Hold
1,995
– – ﹤0.01% 3092
2024
Q3 		$5.49K Hold
1,995
– – ﹤0.01% 3027
2024
Q2 		$4.51K Buy
+1,995
New +$6.06K ﹤0.01% 3041
2021
Q2 		– Sell
-2,845
Closed -$6K – 3127
2021
Q1 		$6K Hold
2,845
– – ﹤0.01% 2977
2020
Q4 		$6K Hold
2,845
– – ﹤0.01% 2937
2020
Q3 		$8K Hold
2,845
– – ﹤0.01% 2806
2020
Q2 		$9K Hold
2,845
– – ﹤0.01% 2770
2020
Q1 		$6K Hold
2,845
– – ﹤0.01% 2750
2019
Q4 		$8K Hold
2,845
– – ﹤0.01% 2803
2019
Q3 		$10K Hold
2,845
– – ﹤0.01% 2747
2019
Q2 		$12K Buy
+2,845
New +$12.3K ﹤0.01% 2721

Other funds holding GALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Wealthspire Advisors (New York)
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ameritas Investment Partners's GALT Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Galectin Therapeutics (GALT) in Q2 2026: 4,349 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #2752 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in GALT as recently as Q1 2025.

Ameritas Investment Partners first reported a position in GALT in Q2 2019 and has held it in 13 quarters since. 98 funds tracked by Wall St. Rank hold GALT as of Q2 2026.

  • Ameritas Investment Partners held 4,349 shares of Galectin Therapeutics worth $20.2K as of Q2 2026.
  • Galectin Therapeutics was a new Ameritas Investment Partners position in Q2 2026.
  • Galectin Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2752 holding.
  • Ameritas Investment Partners first reported a position in Galectin Therapeutics in Q2 2019 and has held it in 13 quarters since.
  • 98 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.